Skip to main content
British Heart Journal logoLink to British Heart Journal
. 1985 Feb;53(2):164–166. doi: 10.1136/hrt.53.2.164

Successful treatment of atrial tachycardias with flecainide acetate.

J E Creamer, A W Nathan, A J Camm
PMCID: PMC481734  PMID: 3966957

Abstract

Intravenous flecainide successfully terminated atrial tachycardia in three patients. Maintenance treatment with oral flecainide prevented the recurrence of tachycardia for up to three years. These results suggest an additional use for flecainide which should be further explored.

Full text

PDF
164

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. L., Stewart J. R., Perry B. A., Van Hamersveld D. D., Johnson T. A., Conard G. J., Chang S. F., Kvam D. C., Pitt B. Oral flecainide acetate for the treatment of ventricular arrhythmias. N Engl J Med. 1981 Aug 27;305(9):473–477. doi: 10.1056/NEJM198108273050901. [DOI] [PubMed] [Google Scholar]
  2. Campbell T. J. Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassification. Cardiovasc Res. 1983 Jun;17(6):344–352. doi: 10.1093/cvr/17.6.344. [DOI] [PubMed] [Google Scholar]
  3. Hellestrand K. J., Bexton R. S., Nathan A. W., Spurrell R. A., Camm A. J. Acute electrophysiological effects of flecainide acetate on cardiac conduction and refractoriness in man. Br Heart J. 1982 Aug;48(2):140–148. doi: 10.1136/hrt.48.2.140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hellestrand K. J., Nathan A. W., Bexton R. S., Spurrell R. A., Camm A. J. Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias. Am J Cardiol. 1983 Mar 1;51(5):770–776. doi: 10.1016/s0002-9149(83)80131-3. [DOI] [PubMed] [Google Scholar]
  5. Hodges M., Haugland J. M., Granrud G., Conard G. J., Asinger R. W., Mikell F. L., Krejci J. Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent. Circulation. 1982 May;65(5):879–885. doi: 10.1161/01.cir.65.5.879. [DOI] [PubMed] [Google Scholar]
  6. Pop T., Treese N., Kang J. C., Meinertz T., Kasper W. Effect of intravenous flecainide on atrial vulnerability in man. Klin Wochenschr. 1983 Jun 15;61(12):609–615. doi: 10.1007/BF01487339. [DOI] [PubMed] [Google Scholar]
  7. Somani P. Antiarrhythmic effects of flecainide. Clin Pharmacol Ther. 1980 Apr;27(4):464–470. doi: 10.1038/clpt.1980.65. [DOI] [PubMed] [Google Scholar]
  8. Verdouw P. D., Deckers J. W., Conrad G. J. Antiarrhythmic and hemodynamic actions of flecainide acetate (R-818) in the ischemic porcine heart. J Cardiovasc Pharmacol. 1979 Jul-Aug;1(4):473–486. doi: 10.1097/00005344-197907000-00010. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES